![]() | |
| Clinical data | |
|---|---|
| Routes of administration | intramuscular |
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 70–100 hours |
| Excretion | renal |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.560 |
| Chemical and physical data | |
| Formula | C19H18N2O3 |
| Molar mass | 322.364 g·mol−1 |
| 3D model (JSmol) | |
| |
| | |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).123
References
References
- Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
- Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.
{{cite book}}: CS1 maint: location missing publisher (link)
